Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 1
2020 2
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
Cutaneous-group histiocytoses associated with myeloid malignancies: A systematic review of 102 cases.
Bonometti A, Gliozzo J, Moltrasio C, Bagnoli F, Berti E. Bonometti A, et al. Australas J Dermatol. 2021 May;62(2):e162-e169. doi: 10.1111/ajd.13491. Epub 2020 Oct 30. Australas J Dermatol. 2021. PMID: 33125722
CONCLUSIONS: Our review shows that generalised eruptions and risk organ involvement in cutaneous-group histiocytosis should raise a suspicion for a concomitant myeloid neoplasm both in children and in adults and warrant further investigations. A rapid recognition of …
CONCLUSIONS: Our review shows that generalised eruptions and risk organ involvement in cutaneous-group histiocytosis should raise a suspicio …
Cutaneous involvement in Ph-negative myeloproliferative neoplasms: from extramedullary hematopoiesis to myeloid metastasis with histiocytic differentiation. A systematic review of the literature.
Bonometti A. Bonometti A. Int J Dermatol. 2023 Oct;62(10):1228-1236. doi: 10.1111/ijd.16809. Epub 2023 Aug 30. Int J Dermatol. 2023. PMID: 37649236 Review.
Myeloid neoplasms may metastasize to the skin, presenting a wide range of clinical-pathological features that often lead to a reduction in patients' survival. The presentation varies depending on the category of myeloid neoplasm and its prognostic significance. The …
Myeloid neoplasms may metastasize to the skin, presenting a wide range of clinical-pathological features that often lead to a reduction in p …
Assessment of Therapy-Related Myeloid Neoplasms in Patients With Neuroendocrine Tumors After Peptide Receptor Radionuclide Therapy: A Systematic Review.
Sonbol MB, Halfdanarson TR, Hilal T. Sonbol MB, et al. JAMA Oncol. 2020 Jul 1;6(7):1086-1092. doi: 10.1001/jamaoncol.2020.0078. JAMA Oncol. 2020. PMID: 32297906
IMPORTANCE: Peptide receptor radionuclide therapy (PRRT) is a tumor-targeted treatment that uses radiation to induce tumor cell death in neuroendocrine tumors (NET) via beta particle-emitting radionuclide linked to a somatostatin peptide analog. Therapy-related myeloid
IMPORTANCE: Peptide receptor radionuclide therapy (PRRT) is a tumor-targeted treatment that uses radiation to induce tumor cell death in neu …